Skip to main content
Premium Trial:

Request an Annual Quote

GeneTrace Introduces High-Throughput SNP Validator

Premium

ALAMEDA, Calif.--GeneTrace Systems, a privately held genomics and bioinformatics company, inaugurated its automated high-throughput single-nucleotide polymorphism (SNP) validation process line last month. Capable of generating SNP data on 10,000 samples per day, it is expected to operate at a rate of 50,000 per day by July.

GeneTrace said it is combining its expertise in marker design, automation, and time-of-flight mass spectrometry to construct tools to study SNPs. George LaMotte, CEO of GeneTrace Systems, said, "The analysis of these new datasets with our bioinformatics tools and integration with our existing database will provide another level of information and value to our partners."

The company's core technology platforms include geno-typing through the characterization of SNPs and microsatellites; high-throughput gene expression screening of chemical treated cells; analysis of gene expression patterns for target discovery; and systems for proteomics analysis. GeneTrace is working with Monsanto to design agricultural applications of its technology focused on genotyping various plants and animals.

Filed under

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.